Sponsor:
Joshua Lawrenz
Code:
NCT04461171
Conditions
Sarcoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enhanced Recovery After Surgery
Brief summary:
Conditions
Sarcoma
Study ID
NCT04461171
Start date
Dec 14, 2020
Status verified date
Nov, 2025
Completion date
Dec, 2026
Anticipated
Primary completion date
Dec, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Treatment
Arms
experimental: ERAS
no intervention: Non-ERAS (Conventional)
Interventions
Enhanced Recovery After Surgery
Primary outcome measure
Central contacts
Locations
Vanderbilt University Medical Center
Recruiting
Nashville, Tennessee, United States, 37232
Contacts
Principal Investigator:
Joshua M Lawrenz, MD
Sponsor
Joshua Lawrenz
Last update posted
Aug 21, 2026
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Joshua Lawrenz on 2026-08-21.